Company attributes
Venture Capital Firm attributes
Other attributes
Clal Biotechnology Industries is a venture capital firm in Israel that focuses on investments in biotechnology companies. Founded 1998 in Ramat Gan, Israel, it invests in early stage ventures, late stage ventures and private equity. Its portfolio companies include Elicio Therapeutics, Anchiano Therapeutics, Colospan, Gamida Cell, Pi-Cardia, Neon Therapeutics, Sight Diagnostics, CureTech, MediWound, and Cadent Therapeutics. As of March 2020, Clal Biotechnology Industries has made 18 investments. Their most recent investment was on October 2, 2019, when Elicio Therapeutics raised $33M. Clal Biotechnology Industries has had seven exits, the most notable of which include Neon Therapeutics, Gamida Cell, and Anchiano Therapeutics. This firm is a life science investment company that focuses on identifying and supporting promising innovative ventures, developing proprietary solutions, addressing unmet medical needs with multibillion-dollar market potential.
